Your browser doesn't support javascript.
loading
Fabry disease cardiomyopathy: from genes to clinical manifestations.
Kertész, Attila Béla; Édes, István.
Afiliación
  • Kertész AB; Nagyerdei krt 98, Debrecen, Hungary, H-4032. kertesz@dote.hu
Curr Pharm Biotechnol ; 13(13): 2477-84, 2012 Oct.
Article en En | MEDLINE | ID: mdl-22280422
Fabry disease is an X chromosome linked disorder caused by the inherited deficiency of lysosomal enzyme α- galactosidase A. The deficiency results in abnormal degradation of certain glycosphingolipids. Although the disease is known for more than hundred years and the underlying molecular basis is getting to be well defined, there are still a lot of unanswered questions regarding the different clinical presentations, available diagnostic procedures and therapeutic interventions. The scope of the article is to review the molecular basis of Fabry disease and summarize the available data about Fabry disease cardiomyopathy, highlight the controversies of current knowledge and evaluate future research directions.
Asunto(s)
Buscar en Google
Bases de datos: MEDLINE Asunto principal: Esfingolípidos / Enfermedad de Fabry / Alfa-Galactosidasa Límite: Humans Idioma: En Revista: Curr Pharm Biotechnol Asunto de la revista: BIOTECNOLOGIA / FARMACOLOGIA Año: 2012 Tipo del documento: Article
Buscar en Google
Bases de datos: MEDLINE Asunto principal: Esfingolípidos / Enfermedad de Fabry / Alfa-Galactosidasa Límite: Humans Idioma: En Revista: Curr Pharm Biotechnol Asunto de la revista: BIOTECNOLOGIA / FARMACOLOGIA Año: 2012 Tipo del documento: Article